Результаты поиска - Ingrid Langsetmo

  • Отображение 1 - 4 результаты of 4
Отмена результатов
  1. 1
    HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques

    HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques по Matthew M. Hsieh, Nathaniel S. Linde, Aisha Wynter, Mark E. Metzger, Carol Wong, Ingrid Langsetmo, Al Lin, Reginald D. Smith, Griffin P. Rodgers, Robert E. Donahue, Stephen J. Klaus, John F. Tisdale

    Опубликовано 2007
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition

    Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition по Ambreena Siddiq, Issam A. Ayoub, Juan C. Chávez, Leila R. Aminova, Sapan Shah, Joseph C. LaManna, Stephanie M. Patton, James R. Connor, Robert A. Cherny, Irene Volitakis, Ashley I. Bush, Ingrid Langsetmo, Todd Seeley, Volkmar Günzler, Rajiv R. Ratan

    Опубликовано 2005
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD

    Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD по Eric D. Labonté, Christopher W. Carreras, Michael R. Leadbetter, Kenji Kozuka, Jill Kohler, Samantha Koo-McCoy, Limin He, Edward E. Dy, Deborah Black, Ziyang Zhong, Ingrid Langsetmo, Andrew Spencer, Noah Bell, Desiree Deshpande, Marc Navre, Jason G. Lewis, Jeffrey Jacobs, Dominique Charmot

    Опубликовано 2014
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease

    Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease по Ughetta del Balzo, Pierre Signore, Gail Walkinshaw, Todd Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael Arend, Lee A. Flippin, F. Aisha Chow, David C. Gervasi, Christian H. Kjaergaard, Ingrid Langsetmo, Volkmar Guenzler, David Y. Liu, S J Klaus, Al Lin, Thomas B. Neff

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: